Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The time window for intravenous recombinant tissue plasminogen activator treatment in ischemic stroke patients has been extended to 4.5h. Little is known about intravenous recombinant tissue plasminogen activator use in the 3-4.5 hour time window among Chinese stroke patients. This exploratory study was to describe the feasibility and outcome of treatment with intravenous recombinant tissue plasminogen activator in the expanded time window, and to offer suggestions for future clinical work in China.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wuhan General Hospital of Guangzhou Military Command
• Treatments: Plasminogen; Tissue Plasminogen Activator

Criteria

Inclusion Criteria:stroke patients in the 3-4.5 hour time window -

Exclusion Criteria:stroke patients in more than 4.5 hour time window

-